Dispersible tablets comprising deferasirox

Details for Australian Patent Application No. 2006303514 (hide)

Owner Novartis AG

Inventors Cassiere, Jean-Pierre; Battung, Florian

Agent Davies Collison Cave

Pub. Number AU-B-2006303514

PCT Pub. Number WO2007/045445

Priority 0553182 19.10.05 FR

Filing date 17 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 24 June 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/045445 Priority application(s): WO2007/045445

24 June 2010 Application Accepted

  Published as AU-B-2006303514

21 October 2010 Standard Patent Sealed

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006303518-Dosing device

2006303502-Dicarboxylic acid derivatives and their use